Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSILODROSTAT vs OSIMERTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSILODROSTAT vs OSIMERTINIB: Safety Overview

Metric OSILODROSTAT OSIMERTINIB
Total FAERS Reports 1,626 27,750
Deaths Reported 191 12,456
Death Rate 11.7% 44.9%
Hospitalizations 526 5,277
Average Patient Age 56.3 yrs 68.2 yrs
% Female Patients 70.8% 66.0%
FDA Approval Date Mar 6, 2020 Nov 13, 2015
Manufacturer Recordati Rare Diseases, Inc. AstraZeneca Pharmaceuticals LP
Route ORAL ORAL
Marketing Status Prescription Prescription